BioMedha is a UK-based pre-clinical CRO providing in vitro biology drug discovery expertise to the global drug discovery industry. We are in vitro biology-focused industry-experienced scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process (Assay development & Screening), such as:

§ Whole blood assays (Immuno-modulation studies)

§ Cell health assays

§ Drug combination studies

§ Functional and expression studies

§ Mitochondrial function

§ Cancer specific cell assays (colony formation, cell adhesion and Invasion, DNA damage etc)

§ Biochemical assays

We have considerable in vitro drug discovery experience in Oncology, Immuno-oncology and CNS therapeutic areas. BioMedha specializes in preclinical in vitro biology capabilities and offers bespoke, high-quality, cost effective services tailored for client needs.